1. health and fitness

2nd Conference
®
15th and 16th April 2015
in Düsseldorf
Patron: Hannelore Kraft,
Prime Minister of the state of
North-Rhine Westphalia (NRW)
www.health3punkt0.de
Premium partner:
Health 3.0
WELCOMING SPEECH
®
Ladies and gentlemen,
The healthcare sector is growing in North-Rhine Westphalia in a very dynamic way and has long become the
largest employer in the state: more than 1.1 million people are working in more than 60,000 companies. This
means every eighth employee is employed in the healthcare sector. The wide range of services being offered in
this sector includes everything from the development
and production of innovative medical technology products and the provision of medical care and nursing services to the research being carried
out at universities and institutes.
support and assistance networks do we need to set up so that citizens
of any age can receive good medical care and at the same time, have all
of their needs heard and taken seriously, not only as a patient but also
as a human being? What steps do we have to take in order to enforce
the human right of self-determination, also in cases of illness or where a
person is in need of nursing care? These are issues which are being successfully addressed not only in politics, but also in the healthcare sector:
Even now we can see many examples of the fact that, orienting health
services to the needs of people and economic efficiency do not have to
be a contraction in terms. Health 3.0 has exactly the right focus with its
triad approach: "innovation - quality - sustainability".
At the same time, the healthcare sector is playing an ever
more important socio-political role, in part due to demographic trends, and more attention must be paid to prevention.
We cannot allow a situation where children have less favourable opportunities in life than their healthy counterparts due
to health restrictions, like malnutrition or motor skill deficits. For this
reason, we must also focus our attention more on how we maintain
good health and how we can protect our health before we become ill.
This, of course, is true for all generations.
If we take the right steps now, soon we will find ourselves not far from
achieving "Health 3.0". With this in mind, I wish you all the best for
your conference.
Hannelore Kraft
Prime Minister of the state of North-Rhine Westphalia (NRW)
At the same time it is becoming ever more important to think about
health and psycho-social factors in conjunction with each other. What
Ladies and gentlemen,
Health 3.0: Tradition meets innovation
– keep what works and foster new ideas and
products.
devices and medical products. At the same time, the issues of quality assurance, efficiency and feasibility also play a role for small and mediumsized companies. Last but not least, the globalisation of the healthcare
market and EU-wide harmonisation are important topics for setting the
direction of future developments in the healthcare system. Know-how,
research and production are increasing becoming interlinked and are
being generated internationally. At the same time, international markets
offer important opportunities for exporting medical technologies and
healthcare models.
The most important challenge for the healthcare system in the future is interlinking innovations in medicine
and medical technology with efficient and patient-focused medical care. This requires strategic reorientation in parts of the healthcare system. Among others,
some important areas for action are: A stronger interdisciplinary approach in the development of technology; facilitation of innovative networks as strategic,
interdisciplinary cooperation efforts between universities, companies, and healthcare providers; focusing the
healthcare system on the needs of patients and users
for providing made-to-measure treatment and care options, coupled
with a high level of transparency in regards to the quality of the care
options available; investments in the infrastructure of the healthcare
system for safely saving and using a large amount of data, as well as
establishing closer links between healthcare, economic, educational
and research policies, which are necessary for this.
Health 3.0 is intended to foster the direction and reorganisation of
these issues, to act as a future-oriented catalyst, and to promote the networking of all of the players in the market. Last but not least, the innovative drive of the healthcare system should be supported in a sustainable
way as economic and growth factors in the present and in the future.
At the present time we are currently experiencing great breakthroughs: The drivers of these changes are the rapid developments in
the areas of analytical medical technologies, personalised medicine
and the imaging methods, as well as the collection of personal data
by the user himself, using end devices such as smartphones. However,
the infrastructure for the management and the interlinking of this huge
amount of data is only sporadically available. In particular, strict requirements for data protection and data quality must be guaranteed
in order to make it possible to use this data on a routine basis. Personalised medicine, telemedical services and assisted living devices for
use when providing care at home to those who require it are futureoriented approaches. An important issue to be discussed in this context
is the issue of the cost/benefit assessment of medical technological
Prof. Dr. Stephanie Stock
Incoming Institute Director of the Institute for Health Economics,
University of Cologne
Dr. Tobias Gantner
Dr
Managing Director, Projekt GmbH Gesundheitsregion KölnBonn
(healthcare region of Cologne-Bonn)
-2-
Health 3.0
WELCOMING SPEECH
®
Ladies and gentlemen,
Health 3.0 - Networks Work
Hardly anyone would dispute how medical treatment
should have been done in a few years. Sector boundaries
will no longer play a role and physicians and non-physicians will work together in trusting partnerships; every
patient will be provided support for as long as necessary,
and there won’t be any more disruptions.
share their information and data with each other safely, quickly and efficiently, and of course, with the best data protection possible. Before the
patient is sent from one ward to the next, his medical records are already
there and he takes an active role in this process. Both hospitals, as well
as registered physicians and non-physicians exchange information with
each other in order to find the right course of treatment.
The industry is lending a helping hand during this change process; it
makes non-technology popular and also paves the way for Health 3.0
with the patients in mind. The policies act as the referee on this playing
field, and they create a basis so that the system can be developed further.
A utopia? I hope not, and my belief that this can be achieved continues
to grow. Yes, this is really true, because I keep meeting more and more
people who know that we cannot overcome future challenges with the
current type of cooperative work being undertaken - or perhaps it would
be better said - with the lack of cooperation that currently exists.
Yes, I am a true believer and I sincerely hope to find a lot of allies during
Health 3.0.
Hence, I truly believe that the system will evolve because individual players
decide to take action, and the number of players which are doing precisely
this will continue to increase.
These changes can be summarised well in the concept of Health 3.0.
The stakeholders in the current system initially have the opportunity to
Jürgen Zurheide
Journalist
©Alex Dumpling
Ladies and gentlemen,
In 2013 Health 3.0 came into existence as a new forum for change, and the start has been quite successful
– even if there have been a few minor stumbling blocks
along the way. The conference showed that the impact
of IT technology and social networks on the healthcare
industry are more serious than previously anticipated.
not as much how we can change and influence systems, but rather how
we can design the systems. And we have a lot to offer in this respect.
Horizon 2020 from Brussels, national healthcare research, regional implementation. The key to success is having joint interdisciplinary teams
made up of representatives from commerce and science and the other
players in the healthcare sector. This is precisely what the organizers of
this conference intend to offer; they are well aware of the social, cultural
and ethical aspects of the developments and see this event as another
small component in facilitating the exchange of information.
People are using the new options available to them, technology is offering them new options, and people's behaviours are changing, as are
the economic processes and value added chains. This dimension is one
of the main issues to be addressed during Health 3.0, so that we can
become aware of the opportunities, risks and consequences that these
developments have on the local healthcare system, industry, the scientific process, and the communities in NRW, Germany & Europe. The
technological revolution, which is incidentally a social and economic
revolution too, has already left its mark in Europe, and the main issue is
Ernst Martin Walsken
Managing Director, public affairs communication GmbH
Dear healthcare activists,
The healthcare markets in industrialised countries are
on the threshold of making a quantum leap in terms of
feasibility, precision and cost controls due to the rapid
technological developments taking place. "Internet of
Things" ,"Wearables", "3-D Production", "Mobile Health" and other basic innovations increase
the levels of transparency and networking while almost
completely dissolving time and spatial dimensions.
nelore Kraft and to the ministers Barbara Steffens, Svenja Schulze and
Garrelt Duin, who are giving a valuable impetus to this event.
This year's focus country is China. Welcome the "experts" and "pros"
from China and let yourself be inspired by a market which has an enormous potential for growth.
Numerous experts will be present, giving interesting presentations and
leading in-depth discussions on sensitive issues.
Unforeseen opportunities open up. But are we also making use of them?
What implications can be derived for the German healthcare market, in
particular for the German healthcare industry? Are we entangled by introducing essential innovations in a "bureaucratic jungle of laws"
and by healthcare insurance cards?
At Health 3.0 we will not avoid addressing controversial issues and we
will address them directly. Come and join us at the event and make your
voice heard. We look forward to seeing you there.
At Health 3.0 you will find out what the current situation is in terms of
the innovative capability and the spirit of innovation that the industry,
providers, insurance agencies, associations and policy makers have.
Hartmut Löw
Managing Director, MCC
At this point, I would like to give special thanks to our patron Ms. Han-
-3-
Health 3.0
Speakers
®
Your moderators
Prof. Dr. Dr. Alexander
P. F. Ehlers
Specialised lawyer for medical
law, & medical physician for
general medicine, Ehlers,
Ehlers & Partner
Prof. Dr. Stephanie
Stock
Incoming Institute
Director of the Institute
for Health Economics,
University of Cologne
Jürgen Zurheide
Journalist
Your experts
Hermann-Josef Arentz,
Owner, Arentz Consulting
Dr. Boris Augurzky,
Divisional Director Health, RWI Managing Director,
Stiftung Münch (Münch Trust)
Dr. Claus W. Biermann,
Chair for General Sociology, Work
and Economics, Faculty of Social
Sciences, Ruhr University Bochum
Matthias Blum,
Managing Director, Krankenhausgesellschaft NRW e.V.
(hospital association in NRW)
Prof. Dr. Angela Brand,
Professor of Social Medicine
& Public Health Genomics,
Maastricht University
Prof. Dr. Helmut Brand,
Head of the International
Health Department, Maastricht University
Jeremy Bray,
Health Directorate of DG
Research and Innovation,
European Commission
Dr. Michael Brinkmeier,
Chairman of the Management
Board, Stiftung Deutsche
Schlaganfall Hilfe (German
trust for stroke assistance)
Dr. Christoph Coch,
Medical specialist for clinical
pharmacology, Institute for Clinical Chemistry & Pharmacology,
University Hospital Bonn
Carsten Coesfeld,
Senior Management, BFS
health finance
Dr. Wolfgang Deiters,
Deputy Institute Director,
Fraunhofer ISST
Garrelt Duin,
Minister for Commerce, Energy, Industry, Medium-Sized
Companies and Skilled Trades
for NRW
Birgit Fischer,
Managing Director, vfa (association of research-based pharmaceutical companies)
Prof. Dr. Ingo Froboese,
Centre for Health through
Sports and Exercise, Sports
University of Applied Sciences Cologne
Christian Fromm,
Authorised representative
of the management board,
CONCILIUS AG
Dr. Tobias Gantner,
Managing Director, Projekt GmbH,
Healthcare region of
Cologne-Bonn
Prof. Dr. Wolfgang Goetzke,
Executive Chairman, Gesundheitsregion KölnBonn e.V.
(healthcare region of CologneBonn)
Prof. Dr. Andreas Goldschmidt,
Managing Director of IHCI, University of Trier
Dr. Lorenz Gräf,
Founder & Managing Director, STARTPLATZ
Christiane Grote,
Group Director - Healthcare
and Nursing Care Market,
Verbraucherzentrale NRW
Prof. Dr. Josef Hilbert,
Managing Director, Institute
for Work and Technology (IAT)
at the Westphalian University
of Applied Sciences
Simone Hoffmann,
Director of Corporate Communications and Marketing,
Paracelsus Kliniken
Dr. Michael Hollmann,
Medicine and Science
Department, FPZ Cologne
Prof. Dr. Christian Hopmann,
Director of the Institute for Plastics Processing (IKV) in Industry
and Skilled Trades, RWTH Aachen
Wilfried Jacobs,
Managing Director, IPOV
GmbH (non-profit institute
for research on patient-oriented healthcare services)
Dr. Albrecht Kloepfer,
Publisher,
GesundheitsPolitischer Brief
(health and politics newsletter)
Dr. Heinrich Körtke,
Director, WZAT (West German
Centre for Applied Telemedicine at the Niederrhein
Lutheran hospital)
Dr. Rolf Koschorrek,
Director, German Professional Association of Ears,
Nose & Throat Physicians
Dr. Nicolas Krämer,
Director of Business Management, Städtische Kliniken Neuss
- Lukaskrankenhaus-GmbH (city
hospitals in Neuss)
Dr. Ralph Kray,
Executive Scholar-in-Residence
in Healthcare, Johns Hopkins
Carey Business School
-4-
Health 3.0
Speakers
®
Your experts
Prof. Dr. Clarissa Kurscheid,
Head of Department,
praxisHochschule University of
Applied Sciences
Dr. Oliver Lehmkühler,
Cluster Manager,
MedizinTechnik.NRW GbR
Alexandra Krieger,
Divisional Director - Business
Management/Company Strategy,
IG Bergbau, Chemie, Energie
(trade union covering mining,
chemicals, energy industries)
Dr. Jan-Christoph Loh,
Managing Partner,
medexo GmbH
Hans Christian Markert,
Member of State Parliament, Speaker for environmental, consumer and
anti-nuclear policies, Bündnis 90/Die
Grünen (Green Party)
Alexander Markowetz,
Associate Professor, Institute
for Information Technology,
Rheinische Friedrich-WilhelmsUniversity Bonn
Prof. Dr. Andreas
Meyer-Falcke,
Deputy Mayor for the capital of
NRW - Düsseldorf, Department
04 - Staff and Health Affairs
Carmen Michels,
Managing Director,
FKuR Kunststoff GmbH
Prof. Dr. Edmund
Neugebauer,
Chairman, DNVF e.V. (German
network of healthcare research)
Jürgen Peukert,
Partner Advisory Services,
EY
Prof. Dr. Holger Pfaff,
Director of the Institute for
Medical Sociology, Healthcare
Research and Rehabilitation Science, University of Cologne
Andreas Propp,
Legal advisor, Joint Federal
Committee (G-BA)
Dirk Ruiss,
Director,
NRW state representative for
vdek (Association of Health
Insurance Companies)
Ulrich Schulze-Althoff,
Managing Director,
MEDISANA AG
Svenja Schulze,
Minister for Innovation, Science and Research in NRW
Carsten Schütz,
Project Manager - Integrated Care FPZ, Pfizer
Pharma GmbH
Prof. Dr. Rainer Sibbel,
International Management,
Frankfurt School of Finance &
Management GmbH
Anke Siebdrat,
Project Manager - Stroke Healthcare Workers, Stiftung Deutsche
Schlaganfall Hilfe (German trust
for stroke assistance)
Barbara Steffens,
Minister for Health, Emancipation, Nursing Care and
the Elderly in NRW
Dr. Sabine Steiner-Lange,
National contact person for health
at the "LifeSciences" National
Contact Point German Aviation &
Aerospace Centre (DLR)
Gerd W. Stürz
Market Segment Leader Life Sciences, Healthcare &
Chemicals in Germany Swiss
Austria, EY
Ulrich Tilly,
Partner, Concilius
Dr. Donata
von Dellingshausen,
Medical Director, BetterDoc
Uwe Wäckers,
Communications Director,
Association for the chemical
industry, NRW state association
Günter Wältermann,
Chairman of the Management Board, AOK Rheinland/
Hamburg
Prof. Dr. Jürgen Wasem,
Alfried Krup von Bohlen und
Halbach - Endowed Professorship for Medical Management,
University of Duisburg-Essen
Dr. Tobias Weimer,
Specialised lawyer for medical law, Weimer/Bork - law
firm for medical, labour &
criminal law
Hans Wormann,
Director of Strategic Business Development, JanssenCilag GmbH
Prof. Mingen Xu,
Deputy Director of the Research Institute of Bio-medical Engineering, Hangzhou
Dianzi University
Dr. Iris Zemzoum,
Managing Director,
Janssen-Cilag GmbH
Marcus Kremers,
Managing Director, MedEcon Telemedizin GmbH
Buy 2 - Get 3!
If you register three individuals from your company, you will receive a
-5-
Angela Lück,
Member of State Parliament,
Deputy Chairman OV, SPD
(Social Democratic Party)
free ticket for the third person.
Health 3.0
Topics
®
1. Patients in the future healthcare system
•
•
•
•
•
•
•
Personalised medicine – specialized beats general?
The "transparent" patient – "big data" or "big brother"?
Digital Transformation of Health
Business model innovation
Second opinion models: Essential or "nice to have"?
Homo Faber: social change through high-tech medicine
Global Health: more social inequality as a result of high-tech innovations?
2. Medical technology: A main area for action in the future
•
•
•
•
•
•
Cornerstone of innovative medical care: the current situation and perspectives
from the viewpoint of the medical device industry
Raw materials - hype: Economy versus ecology?!
Green production technologies put to the test
Sustainable energy and materials management in product development
and production
Telemedicine: Why do technological developments take so long?
Is a new law for restructuring the drug market (AMNOG) on the horizon for
medical technology?
3. European healthcare policies - goal-oriented and visionary?
•
•
•
•
•
•
The Brussels guidelines - status quo and outlook
European healthcare policies: regionalism versus centralism?
Perspectives of European healthcare regions
Healthcare networks on the rise: Healthcare management – across different
sectors and at the local level
Horizon 20/20
"The Payer's Landscape"
4. International: China as the special guest at Health 3.0
•
•
•
•
Pharmaceutical market in China: A market worth billions with flaws?
German-Chinese cooperation efforts in the healthcare industry
Medical know-how: export opportunities and future prospects
Innovation for transplants: the first 3D Bio Printer
An overview of the global EY organisation: The global EY organisation is one of the market leaders for auditing, tax consultancy and management consultancy. With our experience, our know-how and our services, we boost business confidence around the world. The global EY Life
Sciences Center: Competitive pressure due to new entrants into the market, regulatory reforms, expiring patents as well as in the increase in
chronic diseases: The challenges faced by the Life Sciences field are multifaceted. How to react to them? Which business models should be chosen
for the future? Our global Life Sciences Center provides your company with an international team of experts. This will help you to achieve your full
potential. More information is available at www.de.ey.com/lifesciences
Ernst & Young GmbH | Accounting Firm | Graf-Adolf-Platz 15 | 40213 Düsseldorf | Telephone: +49 211 9352 0
-6-
Health 3.0
Programme Day 1
®
Wednesday, 15 April 2015
1st Conference Day:
8:00am Check-in for the attendees and quick breakfast
Presentations in plenum
9:00am Opening speech by the event organizer
9:20am Health 3.0 – Healthcare market undergoing change
Ernst Martin Walsken, Managing Director,
public affairs communication GmbH and
Hartmut Löw, Managing Partner, MCC
Gerd W. Stürz, Market Segment Leader - Life Sciences,
Healthcare & Chemicals in Germany, Switzerland and Austria,
EY
9:10am Welcoming speech and introduction by the
moderator
9:40am The future market of medical technology
– perspectives for NRW
Garrelt Duin, Minister for Commerce, Energy, Industry,
Medium-Sized Companies and Skilled Trades for NRW
Jürgen Zurheide, Journalist
10:00am
Panel discussion:
Agenda 20/20: personalised medicine and modern communications technologies
- What must change in Europe?
Moderators:
Jürgen Zurheide
Birgit Fischer,
Managing
Director, vfa
(association of
research-based
pharmaceutical
companies)
Minister
Garrelt Duin
Prof. Dr.
Angela Brand,
Professor of
Social Medicine
& Public Health
Genomics, Maastricht University
Dr. Iris
Zemzoum,
Managing
Director,
Janssen-Cilag
GmbH
Gerd W. Stürz
10:45am Coffee break and visiting exhibitions
Focus: Pharmaceuticals, pharmaceutical policies, pharmaceutical industry
Parallel forums - Round 1
11:15am
Forum A
11:15am
Effective- safe-expensive? Transparency in the pharmaceuticalmarket for citizens and research
Forum B
Medicinal products covered by insurance companies are
on the rise – Is social exclusion pre-programmed?
Moderators:
Jürgen Zurheide
Moderators:
Dr. Tobias Weimer, Specialised lawyer for medical law,
Weimer/Bork - law firm for medical, labour & criminal law
Günter Wältermann, Chairman of the Management
Board, AOK Rheinland/Hamburg
Prof. Dr. Holger Pfaff, Director of the Institute for Medical
Sociology, Health Services Research and Rehabilitation Science,
University of Cologne
Alexandra Krieger, Head of Business Management/Company Strategy, IG Bergbau, Chemie, Energie (trade union
covering mining, chemicals, energy industries)
Prof. Dr. Jürgen Wasem, Alfried Krupp von Bohlen und
Halbach – Endowed Professorship for Medical Management,
University of Duisburg Essen
Dr. Boris Augurzky, Divisional Director - Health, RWI,
Prof. Dr. Edmund Neugebauer, Chairman, Deutsches
Netzwerk Versorgungsforschung (German network for health
services research)
Managing Director, Stiftung Münch (trust)
Dirk Ruiss, Director, NRW state representative for vdek
(Association of Health Insurance Companies)
-7-
Health 3.0
Programme Day 1
®
12:00noon Presentations in plenum
12:05pm
Panel discussion:
Health care models for the future: "patient-focused", "protected", "safe"
– Patient as organizer of his treatment?
Moderator(s):
Jürgen Zurheide
Barbara
Steffens,
Minister for
Health, Emancipation, Nursing Care
and the Elderly in
North-Rhine Westphalia (NRW)
Wilfried
Jacobs,
Managing
Director, IPOV
GmbH (nonprofit institute
for patientoriented healthcare services
research)
Prof. Dr.
Josef Hilbert,
Managing Director, Institute
for Work and
Technology (IAT)
at the Westphalian University
of Applied Sciences
Ulrich Tilly,
Managing Director, WMP Health
Care GmbH
12:35pm Keynote Speech
Barbara Steffens, Minister for Health, Emancipation,
Nursing Care and the Elderly in North-Rhine Westphalia
(NRW)
12:55pm Lunch break & visiting exhibitions
Innovative forces in the healthcare sector as the engine for working capability and competitive ability
Parallel Forums - Round 2
2:15pm
Forum A
2:15pm
Forum B
Innovations in the German healthcare system: selfimposed obstacles, dispiritedness and protectionism
The healthcare industry in NRW: What are we doing
right and what can we improve?
Moderator:
Dr. Albrecht Kloepfer, Managing Director,
iX-Institute for Healthcare System Development
Moderator:
Dr. Tobias Gantner, Managing Director,
Health Care Futurists GmbH
Introduction: Innovations in the German healthcare system: Where are courage and candour?
Dr. Lorenz Gräf, Founder, Startplatz
Andreas Propp, Legal advisor, Joint Federal Committee
(G-BA)
Ulrich Schulze-Althoff, Managing Director,
MEDISANA AG
Hans Wormann, Director of Strategic Business Development,
Janssen Cilag GmbH
Dr. Christoph Coch, Medical Specialist in Clinical
Pharmacology, Director Centre of Study SZB
Dr. Rolf Koschorrek, Director, German Professional
Association of Ears, Nose & Throat Physicians (e.V.)
Angela Lück, Member of State Parliament,
Deputy Chairman OV, SPD
Hermann-Josef Arentz, Owner, Arentz Consulting
Dr. Donata von Dellingshausen, Medical Director,
BetterDoc
-8-
Health 3.0
Programme Day 1
®
3:00pm Presentations in plenum
3:05pm Commitment to an integrated healthcare approach:
the schizophrenic project in Lower Saxony
Hans Wormann, Director of Strategic Business
Development, Janssen Cilag GmbH
Dr. Iris Zemzoum, Managing Director,
Janssen-Cilag GmbH
3:35pm Data Driven Medicine
Alexander Markowetz, Associate Professor, Institute for
Information Technology, Rheinische Friedrich-Wilhelms
University in Bonn
• Big data and recognising patterns of behaviour
• Ubiquitous tracking, the supreme discipline of data
collection
• Effects on doctors, patients and insurance,
Pharmaceutical companies
4:05pm Coffee break and visiting exhibitions
Health and new media Risks and opportunities for new communication technologies
Parallel Forums - Round 3
4:35pm
Forum A
"M.D.s" beat "Dr. Google"
- Information from the internet
versus the healthcare system
Forum B
4:35pm
4:35pm
Telemedicine as a strategic option
for the development of hospitals?
Moderator:
Prof. Dr. Stephanie Stock,
Incoming Director of the Institute for
Health Economics, University of Cologne
Moderator:
Prof. Dr. Clarissa Kurscheid,
Head of Department, praxisHochschule
University of Applied Sciences
Christiane Grote, Group Director Healthcare and nursing care market,
Consumer Association in NRW
Simone Hoffmann, Director
of Corporate Communications / Marketing, Paracelsus-Kliniken Deutschland
GmbH (corporate branding for hospitals)
Matthias Blum, Managing Director,
NRW Hospital Association (e.V.)
Alexander Markowetz
Dr. Wolfgang Deiters, Deputy Institute Director, Fraunhofer ISST
Dr. Heinrich Körtke, Director of the
Institute for Applied Tele-medicine,
West Germany, Centre for Applied
Telemedicine (WZAT) at the Niederrhein
Lutheran Hospital
Carsten Coesfeld, executive management, BFS health finance
Forum C
Business Model Innovation:
New value added chains in the
healthcare sector
is
am for th
erating te
The mod s not yet been de
g
forum ha or to the printin
pri
termined for this dossier!
deadline
Dr. Nikolas Krämer, Director of
Business Administration,
Lukas Hospital - Neuss
5:20pm Presentations in plenum
SPONSORING / EXHIBITIONS
5:25pm An independent second opinion on telemedicine from experts
Are you interested in positioning your interests, your
companies, your products and services adequately for
your target group?
Then give us a call at:
Dr. Jan-Christoph Loh, Managing Director Managing
Partner, medexo GmbH
• The second opinion via telemedicine
• • Process
• • Experiences and Results
••
Options and Outlook
Tel. +49 (0)2421 12177-19
Ms. Stark would be happy to give you advice.
-9-
Health 3.0
Programme Day 1
®
5:55pm
Discussion panel:
Patient safety / wrong medications / wrong diagnosis:
Risks and opportunities for new communication technologies
Moderator:
Dr. Stephanie
Stock
Dr. Ralph Kray,
Executive Scholarin-Residence in
Healthcare, Johns
Hopkins Carey
Business School
Dr. WolfgangAxel Dryden,
1. Chairman,
KVWL
Marcus
Kremers,
Managing Director, MedEcon
Tele-medizin
GmbH
Carsten
Schütz,
Project Manager Intagrated
Care FPZ, Pfizer
Pharma GmbH
Dr. JanChristoph Loh
7:00pm - 9:30pm
China Night
in cooperation with NRW.Invest and NRW.International
with kind support of the IHK Köln
Health 3.0 - host for top-ranking experts from China cordially invites you to a dialogue.
The Chinese healthcare system is evolving on a continual basis. Mega trends, like "increasing incomes", "the ageing society"
and "the integration of the rural population into the national insurance system" are the driving forces of expansion in this
sector. This opens up opportunities for German producers of medical technology and pharmaceutical products to profit from the rapidly
growing markets.
You will get goal-oriented ideas for your business interactions with China. Join us at the event and help shape the evening!
As discussion partners for you at the event:
Astrid Oldekop,
Consultant, Medienbüro
Düsseldorf/Beijing
Prof. Mingen Xu,
Deputy Director of the Research Institute of Bio-medical
Engineering, Hangzhou Dianzi
University
Prof. Dr. Rainer Sibbel,
International Health Management, Frankfurt School of
Finance & Management gGmbH
With the kind support of:
invite you to a dine with us in the
exhibition area
- 10 -
- 10 -
Christian Fromm,
Authorised representative of the management
board, CONCILIUS AG
Health 3.0
Cooperation and media partners
We would like to thank the following individuals
for their support:
OUR PATRON:
®
Hannelore Kraft
Prime Minister of the
State of NRW
OUR PREMIUM PARTNERS:
OUR MEDIA PARTNERS:
OUR COOPERATION PARTNERS.
vfa is the trade association of research-based pharmaceutical companies in Germany.
It represents the interests of 45 leading research-based pharmaceutical companies and
over 100 subsidiaries and affiliated companies in politics which relate to healthcare,
research and economic affairs.
Claudia Frese | Public Relations Manager| Hausvogteiplatz 13 | 10117 Berlin | Telephone: +49 (0)30 20604 211 | E-Mail: c.frese@vfa.de
- 11 -
Health 3.0
Programme Day 2
®
Thursday 16 April 2015
2nd Conference Day:
Presentations in plenum
9:00am Welcoming speech and introduction held by the
moderator
9:10am Science and research in NRW
– the basis for modern, innovative medicine
Svenja Schulze, Minister for Innovation,
Science and Research in NRW
Prof. Dr. Alexander P. F. Ehlers, Specialised lawyer for
medical law & medical physician for general medicine,
Ehlers, Ehlers & Partner
9:30am
Discussion panel:
Medical products and materials science:
moving away from a throwaway society towards sustainability?
Moderator:
Prof. Dr. Alexander P. F. Ehlers
Prof Dr. Christian Hopmann,
Director of the
Institute for
Plastics Processing
(IKV) in Industry
and Skilled Trades,
RWTH Aachen
Hans Christian
Markert,
Member of State
Parliament, Speaker for environmental, consumer
and anti-nuclear
policies, Bündnis
90/Die Grünen
(Green Party)
Carmen
Michels,
Managing
Director, FKuR
Kunststoff GmbH
Dr. Oliver
Lehmkühler,
Cluster Manager,
MedizinTechnik.
NRW GbR
10:00am Example of innovation: The stroke healthcare workers – better care for stroke victims across all sectors
Dr. Michael Brinkmeier, Chairman of Management Board., Stiftung Deutsche Schlaganfall Hilfe
(German Trust for Stroke Assistance)
Anke Siebdrat, Project Manager Stroke Healthcare workers, Stiftung Deutsche Schlaganfall Hilfe
• Objectives and duties of stroke healthcare workers
• First experience gained
• Political implications and outlook
11:00am Coffee break and visiting the exhibition
Digitalisation as a future driving force: a new era in evidence-based medicine
Parallel Forums - Round 4
11:30 am
Forum A
11:30 am
New avenues for medical technology Market requirements and technologies
Forum B
Digital transformation of health
is
am for th
erating te been ded
o
m
e
Th
s not yet
g
forum ha or to the printin
pri
d
e
in
rm
dossier!
te
is
th
r
fo
deadline
is
am for th
erating te been ded
o
m
e
Th
s not yet
g
forum ha or to the printin
pri
d
e
in
rm
dossier!
te
is
th
r
fo
deadline
-12 -
Health 3.0
Programme Day 2
®
Networks and cooperation efforts in the healthcare industry: collaborate or die?
Parallel Forums - Round 5
12:10am
Forum A
12:10am
Organisation of research associations:
Combined know-how for groundbreaking impetuses
Forum B
Regional networks:
Examples from European countries
Moderator:
Uwe Wäckers, Director of Communications,
VERBAND DER CHEMISCHEN INDUSTRIE e.V. Landesverband NRW (Chemical industry association for NRW)
Moderator:
Prof. Dr. Alexander P. F. Ehlers
Dr. Sabine Steiner-Lange, National Contact Point
- Health at the National Contact Point for Life Sciences,
German Aviation & Aerospace Centre (DLR)
Prof. Dr. Andreas Meyer Falcke, Deputy Mayor,
for Düsseldorf
Dr. Andreas J. W. Goldschmidt, Managing Director of
IHCI, University of Trier
Prof. Dr. Ingo Froboese, Centre for Health through
Sport and Exercise, German Sport University of Applied
Sciences in Köln
Dr. Claus W. Biermann, Chair for General Sociology,
Work and Economics, Ruhr University of Bochum
Anja Sophia Middendorf, Cluster Manager Healthcare Sector, CGW.NRW
EUREGHA, N.N.
12:55pm Presentations in plenum
1:00pm Horizon 2020 – Implications for the European Healthcare Industry
Jeremy Bray, Health Directorate of DG Research and Innovation, European Commission
Presentati
on to be
held in Eng
lish
Since 2014 "Horizon 2020" has been linked with the 7th EU Research Framework Programme (FRP). All programmes sponsored by the
European Commission relating to research and innovation have been brought together under the largest EU research and innovation programme to date. The financial instrument supports the implementation of the Innovation Union, a EU 2020 flagship incentive, for ensuring
Europe's competitiveness in the global marketplace. During a time period of more than 7 years (2014-2020), almost 80 billion euros will be
made available, in addition to private investments.
The programme promises inventions, breakthroughs and world firsts by bringing knowledge and ideas from the laboratory to the European
market. (Editors note)
1:20pm
Discussion panel:
Europe: Shape the future of health together!
Political competencies for shaping the direction on the European level
Moderator:
Prof. Dr. Alexander
P. F. Ehlers
Prof. Dr.
Helmut Brand,
Head of Department of International Health, Uni
Maastricht
Prof. Dr.
Wolfgang Goetzke,
Executive Chairman,
Gesundheitsregion
KölnBonn e.V.
(Healthcare region
Cologne-Bonn)
1:50pm Closing words and farewell from the moderator
2:00pm Lunche - come-together / visiting exhibitions
3:30pm End of conference
- 13 -
Jeremy Bray
Health 3.0
Location
®
Van der Valk Airporthotel Düsseldorf
Contact:
Airporthotel Duesseldorf
Am Hülserhof 57
40472 Düsseldorf, Germany
Tel +49 (0)211 200 63 0
dusseldorf@valk.nl
Directions:
The hotel is centrally located, and at the same time, it is situated in a quite northern neighbourhood of Düsseldorf; it is very
close to the ISS Dome and the motorway junction of the A44 and A52. The hotel soars above the city of Düsseldorf
with its 61 meter-high tower. There is a lake called Silver Lake and a woodland area in the vicinity, which are both great
for riding bikes or taking a walk. The Düsseldorf airport, exhibition centre and city centre can be easily reached in just a few
minutes by car.
During your stay, you are welcome to park your car in one of the 330 free parking spaces located on the hotel's own
parking deck.
Distances:
4 km to the Düsseldorf International Airport
8 km on the motorway to the Düsseldorf Exhibition
Centre
0.5 km to the ISS Dome (multipurpose arena)
8 km to the city centre
2 km to the train station in Unterrath
4 km to the airport train station
0.3 km to the next bus stop
- 14 -
Health 3.0
15th and 16th April 2015 in Düsseldorf
®
Why you should take part in this conference:
The fundamental idea behind Health 3.0 is to reflect on the current
situation in all of the significant areas in the healthcare system.
Obstacles in the development of the healthcare system can be addressed
and be broken down in the dialogue between commerce, politicians, administrators and other players in the healthcare system. Improved and
solution-oriented efforts are required for the future, which first and foremost need to be implemented quickly and in-line with the international
changes taking place in the global healthcare "ecosystem".
Thus, Health 3.0 not only represents a dialogue-oriented event, but it
also will be a results-oriented meeting.
Who should not miss the conference:
The Health 3.0 Conference is especially geared towards doctors, pharmacists, healthcare professionals, nursing staff, hospitals, rehabilitation
centres, university hospitals, research organisations, the pharmaceutical
and medical technology industry, statutory health insurers and private
insurance companies, and the political decision-makers in Europe, as
well as those at the national, state and local levels in Germany.
Yes, I/we will attend the conference on 15th and 16th April 2015 which is
subject to an attendance fee of € 595.- (per person).
Participation conditions:
Buy 2 - Get 3! Yes, I/we would like to register three people from our com-
Please fill out the registration form and return it to MCC as soon as possible either
by fax or by mail. You may also register by email (mcc@mcc-seminare.de). Your
registration in writing is binding. After your filled-out registration form has been
received by MCC, you will receive confirmation letter and an invoice – provided
there are still places available. If that should not be the case, we will inform you
immediately. You can either remit payment of your attendance fees by making a
bank transfer to the bank account indicated on the invoice or you can send us a
non-negotiable cheque.
Buy 2 - Get 3! If three people from your company register for the event, the
ticket for the third person is free of charge.
Please note: You can only take part in the event if your fees have already been
paid or if you make your payment in person at the event itself. The conference
fees will still be due in full after the cancellation deadline passes, even for registered participants who do not attend the event (i.e. "no-shows"). Place of jurisdiction is the city of Düren, Germany. If you want to cancel your registration,
you must do so in writing. Should you cancel your registration prior to 15 March
2015, we will charge you a one-time processing fee in the amount of € 150.- plus
VAT. You will be refunded the attendance fees which you have already paid less
the processing fee. If you cancel your registration after 15 March 2015, your attendance fee cannot be refunded. However, another person may come in on your
behalf if you cannot attend. Please inform us of the name of the person coming in
your place at least three days before the event. Our General Terms & Conditions
shall apply; you may request them from us or you can read them on our website.
pany and get the entrance ticket for the third person for free.
Unfortunately, I cannot attend the conference, however I would like to order
the conference documents, which cost € 195.- plus shipping fees.
(All prices are subject to the statutory Value Added Tax)
Title, Surname
First name
Position
Department
Title, Surname
First name
Position
Department
Title, Surname
First name
Position
Department
1
2
3
Company
Address
Postal code, city, country
Telephone
Fax
Email
Date
Signature and company seal
Find us on Facebook!
www.facebook.de/MCCSeminare
Get more information and register using the QR code and
smartphone.
The organizer reserves the right to make changes to the programme's contents, scheduling and
rooms due to compelling reasons. We assume no liability for printing errors!
Date and event location:
The Conference will take place on 15th and 16th April in
"Van der Valk" Airporthotel Düsseldorf
Am Hülserhof 57, 40472 Düsseldorf
Tel: +49 (0)211 200 63 0 · Fax: +49 (0)211 200 63 200 · info@duesseldorf.valk.
com · Room rate: € 144,- , including VAT, for a single room + breakfast
Reservations
There are a limited number of rooms available which have blocked for the event.
MCC participants will receive special conditions. For this reason, please book your
room well in advance using the keyword "MCC".
Event organizer:
MCC - The Communication Company • Scharnhorststrasse 67a
• 52351 Düren, Germany • Tel.: +49 (0)2421/12177-0 • Fax:
+49(0)2421/12177-27 • eMail: mcc@mcc-seminare.de
• Internet: www.mcc-seminare.de
PA&C Public Affairs & Communication/Ernst Martin Walsken GmbH • Am Thelenbusch 105 • 47269 Duisburg, Germany
• Tel.: +49(0)203/ 34649-26 • Fax: +49(0)203/34649-27 •
eMail: ernst-martin.walsken@t-online.de
• Internet: www.ernst-martin-walsken.de
Please pass this invitation along to your colleagues who may also be interested in attending.
H3-v1.0m
REGISTRATION:
Attendance fee (All prices are subject to the statutory Value Added Tax)
The attendance fee for the two-day event (incl. conference documents, invitation to dinner, luncheons, beverages during the breaks and small snacks) is:
€ 595.-